Further characterization of the variants that we have identified may lead to a deeper understanding of PAP regulation and provide important insights into its effects on prostate cancer, brain cancer, mental health disorders, and neurodegenerative diseases. This evidence concerns the gene ACP3 and prostate carcinoma.